Research Report on Top 50 Companies of China`s Pharmaceutical Industry, 2011-2012

65pages

Published Date: November 2011

Published By: China Research and Intelligence Co., Ltd. (CRI)
Description


Since 2006, the proportion of China pharmaceutical industry output in GDP has remained stable. In the past five years, the proportion fell slightly in 2007, while in other years it kept a growth trend. Especially from 2008H2 to 2009H1, though the global economic development environment generally slowed down, China pharmaceutical industry's performance was still gratifying, showing great development potential. China pharmaceutical industry output growth from CNY 178.14 billion in 2000 to CNY 1,193.38 billion in 2010, with a compound annual growth rate of more than 20%. From January to September 2011, the Chinese medicine industry achieved an output of CNY 1,059.10 billion, increased by 29.1% YOY.

By the end of 2010, there were more than 7,000 pharmaceutical enterprises in China, but the industry concentration was very low. In November 2010, the Chinese Government issued the Guidance on Accelerating Structure Adjustment in Medical Industry, which clearly states that the Chinese Government will support the innovation and technology upgrading of the pharmaceutical industry, promote the M & A and improve industry concentration.

This report analyses the 2010 sales of China's pharmaceutical industry's top 50 companies, including chemical medicine, traditional Chinese medicine, bio-pharmaceuticals and other industries.

By reading this report, readers can get the following information:

  • Major domestic pharmaceutical manufacturing enterprises
  • Major foreign-funded pharmaceutical enterprises in China
  • Major listed pharmaceutical manufacturing enterprises in China
  • The operation of China's main pharmaceutical manufacturing enterprises
The following persons are recommended to purchase this report:

  • Medicine manufacturing enterprises
  • Pharmaceutical trading enterprises
  • Investors concern China pharmaceutical industry
  • Industry research institutes focus on China pharmaceutical industry

 

 

Table Of Content

1 Harbin Pharmaceutical Group Holding CO., LTD

1.1 Enterprise Profiles
1.2 Business Operations
1.3 Development Strategies of Harbin Pharmaceutical Group

2 CSPC Pharmaceutical Group Limited
2.1 Enterprise Profiles
2.2 Business Operations
2.3 Development Strategies of CSPC Pharmaceutical Group

3 Shanghai Pharmaceuticals Holding Co., Ltd
3.1 Enterprise Profiles
3.2 Business Operations

4 Yangtze River Pharmaceutical Group
4.1 Enterprise Profiles
4.2 Business Operations
4.3 Development Strategy

5 Jilin Xiuzheng Pharmaceutical Group
5.1 Enterprise Profiles
5.2 Business Operations

6 Guangzhou Pharmaceutical Holdings Limited
6.1 Enterprise Profiles
6.2 Business Operations

7 Huabei Pharmaceutical Group
7.1 Enterprise Profiles
7.2 Business Operations

8 Buchang Group
8.1 Enterprise Profiles
8.2 Business Operations

9 Tianjin Kingyork Group CO., LTD

10 Bayer Healthcare CO., LTD

11 Tianjin Pharmaceutical Group

12 Northeast Pharmaceutical Group CO., LTD

13 Beijing Tong Ren Tang Group Co., Ltd.

14 Pfizer Inc.

15 Beijing Pharmaceutical Group CO., LTD

16 Tasly Group

17 Qilu Pharmaceutical CO., LTD

18 China National Biotec Group

19 The United Laboratories International Holdings Co., Ltd.

20 Huadong Pharmaceutical Co., Ltd

21 Novonordisk Pharmaceutical Ltd

22 Xian-Janssen Pharmaceutical Ltd

23Sichuan Kelun Pharmaceutical CO., LTD

24 Zhejiang Medicine Co., Ltd

25Jiangxi Jiminkexin Group Co., Ltd

26 Chongqing Taiji Industry (Group) Co., Ltd

27 China Resources Sanjiu Medical & Pharmaceutical Co., Ltd

28 Reyoung Pharmaceutical Co., Ltd

29 Furen Medicine Group

30 Shanghai Fosun Pharmaceutical (Group) Co., Ltd

31 Shanghai Roche Pharmaceutical Co., Ltd

32 Shenzhen Hepalink Pharmaceutical Co., Ltd

33Jiangsu Hengrui Medicine Co., Ltd

34 Yunnan Baiyao Group Co., Ltd

35 Zhejiang NHU Company Ltd

36 Lunan Pharmaceutical Group Co., Ltd.

37 Guangdong Kang Mei Pharmaceutical Co., Ltd

38 Henan Topfond Pharmaceutical Co., Ltd

39 AstraZeneca Pharmaceutical Co., Ltd.

40 Shandong Xinhua Pharmaceutical Group Co., Ltd

41 Jiangsu Xiansheng Pharmaceutical Co., Ltd

42 Beijing Novartis Pharmaceutical Co., Ltd

43 Jiangsu Kanion Pharmaceutical Co Ltd

44 Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd

45 Shanxi Bicon Pharmaceutical Co., Ltd

46 Livzon Pharmaceutical Group Inc.

47 Jiangsu Hanson Pharmaceutical Co., Ltd

48 Zhejiang Conba Pharmaceutical Co., Ltd

49 Shineway Pharmaceutical Group

50 Shouguang Fukang Pharmaceutical Co., Ltd


List Of Figures

Chart 2006-2010 Operating Income of Harbin Pharmaceutical Group
Chart 2006-2010 Operations of Harbin Pharmaceutical Group Holding CO., LTD
Chart 2006-2010 Sales of CSPC Pharmaceutical Group
Chart 2006-2010 Operations of Shanghai Pharmaceuticals Holding Co., Ltd
Chart 2006-2010 Sales of Jilin Xiuzheng Pharmaceutical Group
Chart 2006-2010 Sales of Buchang Group
Chart 2006-2010 Sales of Bayer Healthcare
Chart 2006-2010 Sales of Xi'an-Janssen Pharmaceutical Co., Ltd
Chart 2006-2010 Operations of China Resources Sanjiu Medical & Pharmaceutical Co., Ltd
Chart 2006-2010 Sales of Shanghai Roche Pharmaceuticals Co., Ltd


List Of Tables

NA

More Reports in





» Research Report on China's Anti-Prostatic Hyperplasia (PH) Drug Market, 2013-2017

Benign prostatic hyperplasia (BPH) is a common disease among middle-aged and elderly men, with an increasing morbidity as the rise in ages. Its invasion is possibly related to race and regions.  In China, the PH morbidity of men in urban regions is far higher than that in rural regions. The PH morbidity is influenced by severa...


» Research Report on China's Anti-Alzheimer's Disease (AD) Drug Market, 2013-2017

By the end of 2011, people aged 60 and above reached 185 million in China, accounting for 13.7% of the population, with an increase of 0.47 percentage point compared with that at the end of 2010. The elderly population in China will exceed 200 million by the end of 2013 and reach 221 million in 2015, accounting for 16% of the population, w...


» Research Report on China's Antidepressant Market, 2013-2017

Oct. 10 is "World Mental Health Day". In 2012, its theme is "Depression: a Global Crisis". According to statistics from the United Nations, about 350 million people suffer from depression in the world. Approximately one million people commit suicide every year because of depression. Depression becomes a health crisis worldwide. Depression ...


» Research Report on China's Antifungal Drug Market, 2013-2017

Fungi are usually opportunistic pathogens for healthy human bodies. Under conditions of weakened organism resistance and bad external factors, it is likely to cause general or local fungal infections. In recent years, fungal infection cases tend to gradually increase in China, which is related to following factors to a certain extent: ...


» Research Report on China's Diabetes Drug Market, 2013-2017

Diabetes refers to a series of metabolic disorder syndrome such as sugars, proteins, fat, water and electrolyte that are triggered by islet dysfunction and insulin resistance, and the latter is caused by the actions of various pathogenic factors such as genetic factors, immune disorders, microbial infections and their toxins, free radical t...


» Research Report on China's Automobile Spare Parts Industry, 2013-2017

In China, the automobile spare parts industry refers to the manufacture of motor vehicles and various accessories of their bodies. Automobile spare parts researched in this report mainly include engines, tires, automobile glass, automobile electronics, etc.  With 30 years of development since the reform and opening up, especia...


» Research Report on China's Power Generation Equipment Industry, 2013-2017

Supported by polices of the Chinese government, new energy and clean energy such as nuclear power, wind power and hydropower swiftly and violently develop in China, which drives the continuous increase in the output of generator sets. In 2011, the output of power generation equipment reached 147 million kilowatts nationwide.  ...


» Research Report on China's Urban Rail Transit Industry, 2013-2017

The development of urban rail transit solves the contradiction between distance and time for long-distance transport in working life. In addition, it improves the life quality of residents and promotes the formation of rational layout of cities. In China's history, the first urban rail transit was built in Nanjing in the 1930s, which was d...


» Research Report on China's High-end Medical Treatment Industry, 2013-2017

In recent years, the market size of China's medical services continuously expands, but whole medical services are on the rather low level. The rich and foreigners in China attach importance to quality and privacy of medical services and they are unwilling to accept the noisy and crowded hospital environment and inferior service attitudes o...


» Research Report on China's Antithrombotic Drug Market, 2013-2017

Thrombosis refers to the formation of local blood clots. Among it, artery thrombosis can cause myocardial infarction, stroke, acute coronary syndrome, peripheral arterial diseases, etc.; venous thrombosis can cause pulmonary embolism. Arteriovenous thrombosis is the primary reason for incidence and death of cardiovascular diseases, which i...



Related News

News Sep 18, 2012

Premiers of China and Kyrgyzstan Agree to Advance Agricultural Collaboration

The meet between Vice Premier of China Hui Liangyu and the Kyrgyz President Almazbek Atambayev has brought in food news for the agriculture industry. Both the countries have agreed to further boost mutual trade and industry cooperation, especiall...

News Sep 13, 2012

Chinese Solar Companies Gear-Up for EU Anti-Dumping Probe, Ask to End Protectionism

Reacting strongly towards the European Commission’s (EU) impending anti-dumping probe into Chinese solar panel imports, China has called the decision ‘regrettable’ and said that it will have negative effects on the trade relatio...

News Sep 11, 2012

Mendel Biotechnology Co and Bayer Develop Herbicide Resistance Breaking Technology

Mendel Biotechnology and Bayer CropScience have collaborated to jointly come up with a herbicide with novel modes of action. There is increasing evidence of weeds resistant to herbicides in different geographies, including those that are resistan...

News Aug 25, 2012

Global Health-Care Market

Global health-care spending, with its current rate of growth is expected to doubleby year 2020 and reach a market size worth USD 70.9 trillion, accountingfor almost 25-30 percent of Global GDP.The rise in spending is attributed to growth of healt...

News Aug 25, 2012

Global Hospital Investment Market

Hospital investment deals with the capital flows and investment trends in hospital construction market. Global healthcare investment market is segmented in two categories – Public hospital sectors and Private hospital sectors Contin...

News Aug 25, 2012

Global Medical Simulation Market

Medical simulation is a training method used to train different processes and tasks to medical professionalsin life like circumstances. Theprocess requires several tools or equipment which includes models, actor-patients, peers, surveillance and ...

News Aug 24, 2012

Chinese Solar Industry smacked by Weak Sales

The Solar industry in china is seeing a downturn after a robust growth in the last decade. The industry has suffered huge financial losses due to decrease in sales worldwide. Another reason for this downturn is the ongoing price war between other...

News Aug 24, 2012

China Paving Way for Jet Biofuels

Boeing and COMAC – Commercial Aircraft Corporation of China have established a new laboratory in Beijing which shall perform research upon creating a method of refining “gutter oil” – waste cooking oil and create jet fuel....

News Aug 24, 2012

Chinese Firm taps at Rockville Biotech for Vaccine Technology

A Chinese company is being tapped by the drug manufacturer Rockville Biotech Fina Solutions for vaccine technology. Rockville Biotech is licensing the firm to manufacture pneumonia vaccine by using its developed technology. Rockville Biot...

News Aug 24, 2012

Package Delivery Industry Set to Boom in China

Following the lead of the U.S. and Japan, China has evolved as the third largest package delivery market in the world. In the year 2011 more than 7,500 package delivery companies were operating in China. Every day, approximately 130 million packa...








All Rights Reserved   Latest News   Latest Reports